Precision BioSciences (NASDAQ:DTIL) is up 3.2% postmarket after an initiation at Buy by Stifel.
Analyst Benjamin Burnett set a price target of $21, implying 159% upside from the $8.11 close.
https://seekingalpha.com/news/3548839-precision-biosciencesplus-3_2-on-bullish-stifel-start
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.